{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:02:08Z","timestamp":1788224528222,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Capital Region of Denmark; Amager Hvidovre University Hospital Research Foundation"},{"name":"Sophus Jacobsen\u2019s Fond"},{"name":"the Liver Disease Foundation at Amager and Hvidovre University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50883-7","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:56:52Z","timestamp":1777355812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Magnetic resonance imaging-derived extracellular volume fraction mapping in metabolic dysfunction-associated steatotic liver disease reveals subclinical cardiac remodelling"],"prefix":"10.1038","volume":"16","author":[{"given":"Puria","family":"Nabilou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv E.","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel Parsberg","family":"Werge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Badal","family":"Rashu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Thing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Ellekaer","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Barl\u00f8se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Siebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Bendtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D.","family":"Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"5","key":"50883_CR1","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.23988","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 52 (5), 1836\u20131846. (2010). https:\/\/doi.org\/10.1002\/hep.23988","journal-title":"Hepatology"},{"issue":"8","key":"50883_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65 (8), 1038\u20131048. (2016). https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012","journal-title":"Metabolism"},{"key":"50883_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922. (2018). https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat. Med."},{"key":"50883_CR4","doi-asserted-by":"publisher","unstructured":"Vieira Barbosa, J. et al. Fibrosis-4 index can independently predict major adverse cardiovascular events in nonalcoholic fatty liver disease. Am. J. Gastroenterol. (2022). https:\/\/doi.org\/10.14309\/ajg.0000000000001606","DOI":"10.14309\/ajg.0000000000001606"},{"key":"50883_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.1809","author":"P Ochoa-Allemant","year":"2025","unstructured":"Ochoa-Allemant, P., Hubbard, R. A., Kaplan, D. E. & Serper, M. Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2025.1809 (2025).","journal-title":"JAMA Intern. Med."},{"issue":"7","key":"50883_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"Cusi, K. et al. Metabolic dysfunction\u2013associated steatotic liver disease (masld) in people with diabetes: the need for screening and early intervention. a consensus report of the american diabetes association. Diabetes Care. 48 (7), 1057\u20131082. (2025). https:\/\/doi.org\/10.2337\/dci24-0094","journal-title":"Diabetes Care"},{"key":"50883_CR7","doi-asserted-by":"publisher","unstructured":"Badve, S. V. et al. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 13 (1), 15\u201328. https:\/\/doi.org\/10.1016\/S2213-8587(24)00271-7 (Jan. 2025).","DOI":"10.1016\/S2213-8587(24)00271-7"},{"issue":"21","key":"50883_CR8","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","volume":"392","author":"AJ Sanyal","year":"2025","unstructured":"Sanyal, A. J. et al. Phase 3 trial of semaglutide in metabolic dysfunction\u2013associated Steatohepatitis. N Engl. J. Med. 392 (21), 2089\u20132099. (2025). https:\/\/doi.org\/10.1056\/NEJMoa2413258","journal-title":"N Engl. J. Med."},{"issue":"9","key":"50883_CR9","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/liv.13870","volume":"38","author":"S Wiese","year":"2018","unstructured":"Wiese, S. et al. Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome. Liver Int. 38 (9), 1614\u20131623. (2018). https:\/\/doi.org\/10.1111\/liv.13870","journal-title":"Liver Int."},{"key":"50883_CR10","doi-asserted-by":"publisher","unstructured":"de Terzi, F. V. et al. How cardiac fibrosis assessed via T1 mapping is associated with liver fibrosis in patients with non-alcoholic fatty liver disease. J. Clin. Med. 12 (23). https:\/\/doi.org\/10.3390\/jcm12237381 (2023).","DOI":"10.3390\/jcm12237381"},{"issue":"1","key":"50883_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1148\/radiol.2020191949","volume":"296","author":"J Chen","year":"2020","unstructured":"Chen, J., Yin, M., Talwalkar, J. A. & others MR elastography and extracellular volume fraction mapping in chronic liver disease: Relationship to histopathology. Radiology 296 (1), 79\u201388. (2020). https:\/\/doi.org\/10.1148\/radiol.2020191949","journal-title":"Radiology"},{"issue":"2","key":"50883_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/MPA.0000000000001742","volume":"50","author":"A Masamune","year":"2021","unstructured":"Masamune, A., Kikuta, K., Takikawa, T. & others Extracellular volume fraction of pancreatic parenchyma quantified by magnetic resonance imaging reflects the degree of fibrosis in chronic pancreatitis. Pancreas 50 (2), 192\u2013198. (2021). https:\/\/doi.org\/10.1097\/MPA.0000000000001742","journal-title":"Pancreas"},{"issue":"2","key":"50883_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00261-019-02384-7","volume":"45","author":"Y Noda","year":"2020","unstructured":"Noda, Y. et al. Pancreatic extracellular volume fraction using T1 mapping in patients with impaired glucose intolerance. Abdom. Radiol. 45 (2), 449\u2013456. (2020). https:\/\/doi.org\/10.1007\/s00261-019-02384-7","journal-title":"Abdom. Radiol."},{"key":"50883_CR14","doi-asserted-by":"publisher","unstructured":"Sun, S. et al. Prediction of pancreatic fibrosis by dual-energy CT-derived extracellular volume fraction: Comparison with MRI. Eur. J. Radiol. 170, 111204. (2024). https:\/\/doi.org\/10.1016\/j.ejrad.2023.111204","DOI":"10.1016\/j.ejrad.2023.111204"},{"key":"50883_CR15","doi-asserted-by":"publisher","unstructured":"de Meester de, C. et al. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T. J. Cardiovasc. Magn. Reson. 17 (1), 48. (2015) https:\/\/doi.org\/10.1186\/s12968-015-0150-0","DOI":"10.1186\/s12968-015-0150-0"},{"key":"50883_CR16","doi-asserted-by":"publisher","unstructured":"Lurz, J. A. et al. CMR\u2013Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis. JACC Cardiovasc. Imaging. 11 (1), 38\u201345. (2018) https:\/\/doi.org\/10.1016\/j.jcmg.2017.01.025","DOI":"10.1016\/j.jcmg.2017.01.025"},{"issue":"7","key":"50883_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher, G., Valenti, L. & Byrne, C. D. Metabolic dysfunction\u2013associated steatotic liver disease. N Engl. J. Med. 393 (7), 683\u2013698. (2025). https:\/\/doi.org\/10.1056\/NEJMra2412865","journal-title":"N Engl. J. Med."},{"issue":"2","key":"50883_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","volume":"81","author":"RK Sterling","year":"2025","unstructured":"Sterling, R. K. et al. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology 81 (2), 672\u2013724. (2025). https:\/\/doi.org\/10.1097\/HEP.0000000000000843","journal-title":"Hepatology"},{"issue":"6","key":"50883_CR19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (6), 1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701 (2005).","journal-title":"Hepatology"},{"issue":"5","key":"50883_CR20","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal, F. et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology 161 (5), 1657\u20131669. (2021). https:\/\/doi.org\/10.1053\/j.gastro.2021.07.049","journal-title":"Gastroenterology"},{"key":"50883_CR21","doi-asserted-by":"publisher","unstructured":"Rinella, M. E. et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77 (5), 1797\u20131835. (2023) https:\/\/doi.org\/10.1097\/HEP.0000000000000323","DOI":"10.1097\/HEP.0000000000000323"},{"key":"50883_CR22","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"EASL-EASD-EASO","year":"2016","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388\u20131402. (2016). https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004","journal-title":"J. Hepatol."},{"issue":"1","key":"50883_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mrm.20110","volume":"52","author":"DR Messroghli","year":"2004","unstructured":"Messroghli, D. R. et al. Modified Look-Locker inversion recovery (MOLLI) for high\u2010resolution T 1 mapping of the heart. Magn. Reson. Med. 52 (1), 141\u2013146. (2004). https:\/\/doi.org\/10.1002\/mrm.20110","journal-title":"Magn. Reson. Med."},{"issue":"2","key":"50883_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/HEP.0000000000000735","volume":"82","author":"S Driessen","year":"2025","unstructured":"Driessen, S. et al. Metabolic dysfunction-associated steatotic liver disease and the heart. Hepatology 82 (2), 487\u2013503. (2025). https:\/\/doi.org\/10.1097\/HEP.0000000000000735","journal-title":"Hepatology"},{"key":"50883_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2025.04.012","author":"B Bansal","year":"2025","unstructured":"Bansal, B., Lajeunesse-Trempe, F., Keshvani, N., Lavie, C. J. & Pandey, A. Impact of metabolic dysfunction\u2013associated steatotic liver disease on cardiovascular structure, function, and the risk of heart failure. Can. J. Cardiol. (2025). https:\/\/doi.org\/10.1016\/j.cjca.2025.04.012","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"50883_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1148\/radiol.2020201057","volume":"297","author":"A Isaak","year":"2020","unstructured":"Isaak, A. et al. Myocardial fibrosis and inflammation in liver cirrhosis: MRI study of the liver-heart axis. Radiology 297 (1), 51\u201361. (2020). https:\/\/doi.org\/10.1148\/radiol.2020201057","journal-title":"Radiology"},{"key":"50883_CR27","doi-asserted-by":"publisher","unstructured":"Erley, J. et al. Novel insights into cardiac structure, function, perfusion, and tissue characteristics in liver cirrhosis: a magnetic resonance analysis. Eur. Radiol. 1\u201310. (2025). https:\/\/doi.org\/10.1007\/s00330-025-11710-1","DOI":"10.1007\/s00330-025-11710-1"},{"issue":"3","key":"50883_CR28","doi-asserted-by":"publisher","first-page":"G253","DOI":"10.1152\/AJPGI.00402.2018","volume":"317","author":"S Wiese","year":"2019","unstructured":"Wiese, S. et al. Cardiac dysfunction in cirrhosis: A 2-yr longitudinal follow-up study using advanced cardiac imaging. Am. J. Physiol. - Gastrointest. Liver Physiol. 317 (3), G253\u2013G263. (2019). https:\/\/doi.org\/10.1152\/AJPGI.00402.2018","journal-title":"Am. J. Physiol. - Gastrointest. Liver Physiol."},{"key":"50883_CR29","doi-asserted-by":"publisher","unstructured":"Soultoukis, G. A. et al. Pancreatic stellate cells have adipogenic and fibrogenic potentials but only show increased pro-fibrogenic propensity upon aging. Redox Biol. 86, 103791. (2025). https:\/\/doi.org\/10.1016\/j.redox.2025.103791","DOI":"10.1016\/j.redox.2025.103791"},{"key":"50883_CR30","doi-asserted-by":"publisher","unstructured":"Johansen, C. G. et al. Extracellular matrix stiffness mediates insulin secretion in pancreatic islets via mechanosensitive Piezo1 channel regulated Ca2\u2009+\u2009dynamics. Matrix Biol. Plus. 22, 100148. (2024) https:\/\/doi.org\/10.1016\/j.mbplus.2024.100148","DOI":"10.1016\/j.mbplus.2024.100148"},{"issue":"3","key":"50883_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12020-023-03592-4","volume":"83","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y. et al. The collagen matrix regulates the survival and function of pancreatic islets. Endocrine 83 (3), 537\u2013547. (2023). https:\/\/doi.org\/10.1007\/s12020-023-03592-4","journal-title":"Endocrine"},{"key":"50883_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mri.2019.03.002","volume":"59","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Assessing liver fibrosis in chronic hepatitis B using MR extracellular volume measurements: Comparison with serum fibrosis indices. Magn. Reson. Imaging. 59, 39\u201345. (2019). https:\/\/doi.org\/10.1016\/j.mri.2019.03.002","journal-title":"Magn. Reson. Imaging"},{"issue":"1","key":"50883_CR33","doi-asserted-by":"publisher","first-page":"9422","DOI":"10.1038\/s41598-022-13340-9","volume":"12","author":"N Mesropyan","year":"2022","unstructured":"Mesropyan, N. et al. Assessment of liver cirrhosis severity with extracellular volume fraction MRI. Sci. Rep. 12 (1), 9422. (2022). https:\/\/doi.org\/10.1038\/s41598-022-13340-9","journal-title":"Sci. Rep."},{"issue":"3","key":"50883_CR34","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1148\/radiol.2018180051","volume":"288","author":"JA Luetkens","year":"2018","unstructured":"Luetkens, J. A. et al. Quantification of liver fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: preclinical results. Radiology 288 (3), 748\u2013754. (2018). https:\/\/doi.org\/10.1148\/radiol.2018180051","journal-title":"Radiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50883-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:59:05Z","timestamp":1782716345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50883-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50883"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50883-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19644"}}